Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data-Reference-Cited by-同舟云学术

Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data

Published:2022-02-23 Issue:1 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Fu Yunfeng¹²,Li Xiao²,Li Ying¹²^ORCID,Lu Weiguo²,Xie Xing²,Wang Xinyu²^ORCID

Affiliation:

1. Centre for Diagnosis & Treatment of Cervical Diseases, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China

2. Department of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China

Abstract

The benefits of testing for high-risk human papillomavirus (hrHPV) in cervical cancer screening have already been demonstrated. Hybrid Capture 2 (HC2) is the best validated HPV assay and has been considered the gold standard for hrHPV testing.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01570-21

Reference19 articles.

1. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

2. Human papillomavirus and cervical cancer

3. Human Papillomavirus Testing in the Prevention of Cervical Cancer

4. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

5. Are 20 human papillomavirus types causing cervical cancer?

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening Methods for Cervical Cancer;ChemMedChem;2024-06-19

2. Risk stratification for cervical precancer and cancer by DH3‐HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study;Journal of Medical Virology;2023-01-13

3. Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses?;Frontiers in Public Health;2022-11-09